NASDAQ: PACB
Pacific Biosciences of California, Inc.
Healthcare · Medical - Devices
Market Cap
$447.27M
52w High
$2.73
52w Low
$1.09
P/E
-3.35
Volume
780.85K
Outstanding Shares
310.60M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 2.16% over the last year. Revenue grew 5.04% over the trailing twelve months. Operating margin moved from -539.45% to -101.72%. Free cash flow grew 36.54% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -101.72%. A decisive move in revenue — currently up 5.04% — would be the clearest signal to resolve the ambiguity.
Company profile
Pacific Biosciences of California, Inc. (PACB) specializes in pioneering and manufacturing advanced genetic sequencing platforms, empowering researchers and institutions to unravel intricate genetic challenges.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
9
Buy
8
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 3, 2026
Q3 FY26 · EPS est -$0.13 · Revenue est $42.9M
View